Загрузка...
COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report
By the beginning of the global pandemic, SARS-CoV-2 infection has dramatically impacted on oncology daily practice. In the current oncological landscape, where immunotherapy has revolutionized the treatment of several malignancies, distinguishing between COVID-19 and immune-mediated pneumonitis can...
Сохранить в:
| Опубликовано в: : | J Immunother Cancer |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7880093/ https://ncbi.nlm.nih.gov/pubmed/33574054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001870 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|